Ordering Information

How
Supplied

Ordering Information

US WorldMeds offers a minimum order of 1 carton (6 vials), a free reminder service and several easy ways to order Revonto. It is available on your GPO contract as a dropship via your wholesaler/distributor. Below you will find the item numbers associated with Revonto.

For more information call: (877) 411-USWM (8796)
After Hours/Emergency Order Information: (866) 916-0581

Ordering Revonto
	USWorldMeds label 20 mg Revonto Cartons of 6 vials, 65 mL vial NDC# 27505-001-65	NovaPlus label 20 mg Revonto Cartons of 6 vials, 65 mL vial NDC# 27505-001-66
ABC	620-841	620-854
Cardinal	4008231	4008249
McKesson	1787795	1776418
Morris & Dickson	757625	757633
HD Smith	209-2823	209-2716
CuraScript	220299	220310
Besse Medical	30519	30520
Dakota Drug	653279	—
PSS World Medical	198124	—
Henry Schein	1102375	—
McKesson Medical-Surgical	662858	—
Southern Anesthesia	Please call customer service	—

Please see full prescribing information for Revonto.

US WorldMeds has partnered with the Nursing CE Portal to offer for a limited time a free online class entitled "Malignant Hyperthermia: Perioperative Crisis," worth one contact hour. Click here to register.

For More information on Malignant Hyperthermia please visit The Malignant Hyperthermia Association of the United States (MHAUS).

Home / What is Malignant Hyperthermia (MH)? / About Revonto / Frequently Asked Questions / Ordering Information / Contact Us
Full Prescribing Information / Clinical Pharmacology / Indications and Usage / Dosage and Administration / How Revonto is Supplied
Privacy Policy / Terms of Use / US WorldMeds Home

Important Safety Information

Revonto is indicated, along with appropriate supportive measures, for the management of fulminant hypermetabolism of skeletal muscle characteristic of malignant hyperthermia crises in patients of all ages. It is also indicated preoperatively and sometimes postoperatively, to prevent or attenuate the development of clinical and laboratory signs of malignant hyperthermia in individuals judged to be malignant hyperthermia susceptible. Malignant hyperthermia is life threatening and requires immediate medical attention and treatment. Fatal and non-fatal liver disorders of an idiosyncratic or hypersensitivity type may occur with dantrolene sodium therapy. There have been reports of thrombophlebitis following administration of intravenous dantrolene. There have been rare reports of urticaria and erythema possibly associated with the administration of i.v. dantrolene sodium.

CONTRAINDICATIONS: None.

For additional information, see full prescribing information for Revonto.